Equities

Modular Medical Inc

MODD:NAQ

Modular Medical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.55
  • Today's Change-0.015 / -0.96%
  • Shares traded22.45k
  • 1 Year change-17.99%
  • Beta-0.1928
Data delayed at least 15 minutes, as of May 01 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Modular Medical, Inc. is a development stage, medical device company. The Company is focused on the design, development, and commercialization of an insulin pump using modernized technology to increase pump adoption in the diabetes marketplace. The Company, through the creation of two-part patch pump, MODD1, seeks to serve both the type 1 and type 2 diabetes markets. The Company, using its methods of insulin measurement, is able to eschew complex mechanisms and instead build a product candidate using only parts from high volume consumer electronics manufacturing lines. It provides an insulin pump, which has both basal (steady flow) and bolus (mealtime dosing) insulin disbursement. It also consists of a natural migration path to multi-chamber/multi-liquid pumps, potentially offering an array of new therapies to patients with diabetes and other conditions.

  • Revenue in USD (TTM)0.00
  • Net income in USD-16.76m
  • Incorporated1998
  • Employees37.00
  • Location
    Modular Medical Inc16772 WEST BERNARDO DRIVESAN DIEGO 92127United StatesUSA
  • Phone+1 (858) 800-3500
  • Fax+1 (775) 786-6755
  • Websitehttps://www.modular-medical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lexaria Bioscience Corp404.72k-5.44m44.97m5.00--6.63--111.12-0.6851-0.68510.04930.52640.0722--1.6480,944.00-97.62-95.67-94.18-96.5895.6676.98-1,351.64-1,612.76---175.330.00---11.43-12.198.31------
Rockwell Medical Inc80.83m-9.29m45.22m253.00--2.04--0.5595-0.5462-0.54624.260.75531.5113.839.66319,494.10-17.40-53.82-28.13-73.1010.111.75-11.49-46.171.06-6.740.3517--17.574.9142.83---30.09--
Immuneering Corp0.00-53.47m45.37m68.00--0.4945-----1.89-1.890.003.090.00----0.00-47.54---51.16--------------0.00---100.00---5.86------
IN8BIO, Inc.0.00-30.01m45.78m31.00--1.81-----1.02-1.020.000.57610.00----0.00-89.91-74.18-108.07-84.42------------0.0466-------5.21---4.54--
Matinas BioPharma Holdings Inc1.10m-22.94m45.80m32.00--2.06--41.79-0.1056-0.10560.0050.08860.0314----34,250.00-65.62-44.62-72.81-48.25-----2,093.25-2,344.60----0.0012---65.6255.71-9.26---16.46--
Eyenovia Inc3.79k-27.26m46.63m57.00--4.63--12,302.49-0.6639-0.66390.000090.19760.0001--0.003166.49-91.15-80.31-119.11-117.700.00---719,290.30-680.952.16-15.140.6135------2.68--152.20--
Arca Biopharma Inc0.00-6.00m47.13m4.00---------0.4155-0.41550.00--------0.00---27.78---29.38--------------------46.21------
Aadi Bioscience Inc24.35m-65.77m47.64m74.00--0.4528--1.96-2.44-2.440.90494.280.15380.67796.63273,640.40-41.54-50.25-48.46-56.1588.47---270.04-473.974.48--0.00--60.063.85-8.68--153.54--
Movano Inc0.00-29.28m47.81m30.00--7.88-----0.6463-0.64630.000.06180.00----0.00-258.41-151.50-496.87-188.58--------1.26--0.014------3.45--4.24--
Modular Medical Inc0.00-16.76m48.03m37.00--8.59-----0.9653-0.96530.000.18050.00----0.00-224.40-168.16-262.22-209.51------------0.00------25.51--154.53--
Journey Medical Corp79.18m-3.85m48.90m58.00--3.33--0.6176-0.3502-0.35024.191.050.87012.193.651,365,190.00-4.23---10.51--66.33---4.87--1.100.68630.4641--7.48--87.00------
Checkpoint Therapeutics Inc103.00k-51.85m49.96m23.00------485.06-2.93-2.930.0055-0.47030.011----4,478.26-555.46-142.43---342.79-----50,336.89-6,554.97---------46.35-50.6117.21------
Odonate Inc0.00-102.07m50.02m137.00--1,844.41-----13.59-13.590.009.270.00----0.00-66.98-58.36-83.00-65.14------------0.00-------12.99------
Medicine Man Technologies Inc172.45m-42.70m50.86m729.00--0.403--0.2949-1.60-1.603.011.610.50643.9939.49236,553.90-10.15-8.33-11.95-9.8544.0845.57-20.03-15.710.50270.31430.5679--8.2078.78-62.56--200.89--
Data as of May 01 2024. Currency figures normalised to Modular Medical Inc's reporting currency: US Dollar USD

Institutional shareholders

23.58%Per cent of shares held by top holders
HolderShares% Held
Manchester Management Co. LLCas of 16 Feb 20243.59m11.60%
683 Capital Management LLCas of 16 Feb 20241.57m5.07%
Solas Capital Management LLCas of 31 Dec 20231.02m3.28%
Sio Capital Management LLCas of 31 Dec 2023689.35k2.22%
The Vanguard Group, Inc.as of 31 Dec 2023123.80k0.40%
Geode Capital Management LLCas of 31 Dec 202396.04k0.31%
Perritt Capital Management, Inc.as of 31 Dec 202385.00k0.27%
William Blair Investment Management LLCas of 31 Dec 202365.59k0.21%
Renaissance Technologies LLCas of 31 Dec 202344.50k0.14%
Bank of America, NA (Private Banking)as of 31 Dec 202324.68k0.08%
More ▼
Data from 31 Dec 2023 - 16 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.